Recombinant fusion protein PTD-HSP27 and use thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 钟敬祥
- Publication Date
- 2012-12-19
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of genetic engineering, specifically to the field of design and recombinant fusion protein technology, in particular to a recombinant fusion protein PTD-HSP27 and its application. Background technique
[0002] Cataract, a disease that occurs on the lens inside the eye, is the most common cause of blindness and visual impairment. Analyzing and exploring the development process and pathogenesis of cataract, and developing effective drugs for the prevention and treatment of cataract have important social benefits. Studies have confirmed that apoptosis is earlier than cataract in space and time, and it is deduced that lens epithelial cell apoptosis may be the common cellular basis of various cataracts. The mechanism of cell apoptosis believes that if the epithelial cells undergo apoptosis, the growth of the lens will stagnate, and the lens epithelial cells (LEC) will fall off, which will lead to a series of chang...